Workflow
坚守“硬科技”定位 科创板闯出一条高质量发展之路
Zheng Quan Ri Bao·2025-06-18 16:10

Core Points - The implementation of the "Eight Measures for Deepening the Reform of the Sci-Tech Innovation Board" has significantly improved the financing environment for technology innovation companies, allowing more qualified firms to go public and focus on technological innovation and product development [1][2] - The Sci-Tech Innovation Board has become a primary platform for "hard technology" companies, with over 80% of the 588 listed companies coming from key technology sectors such as integrated circuits, biomedicine, and high-end equipment [2][3] - The board has facilitated the construction of self-sufficient industrial chains, particularly in the integrated circuit sector, which includes 119 companies covering the entire supply chain from chip design to packaging and testing [2][3] Industry Development - The "Eight Measures" have led to a clustering effect in the technology sector, with companies like YingShi Innovation Technology Co., Ltd. achieving a market capitalization exceeding 70 billion yuan on their first day of listing [2] - Many companies in the integrated circuit field are actively building autonomous industrial chains, with firms like Shenzhen Baiwei Storage Technology Co., Ltd. focusing on R&D and production capabilities [3] - The utilization rates of wafer manufacturing companies listed on the Sci-Tech Innovation Board remain high, indicating a robust production and sales environment [3] International Expansion - Sci-Tech Innovation Board companies are accelerating their internationalization strategies, with total overseas revenue reaching 430.36 billion yuan in 2024, a year-on-year increase of 6.1% [4] - High-value product exports and a dual approach of technology and capital are becoming key drivers for the international competitiveness of these companies [4] - The biopharmaceutical sector has also seen significant growth, with 113 companies listed and successful global drug launches, indicating a strong position in the global innovative drug market [5] Future Outlook - There is optimism regarding the continued reform of the Sci-Tech Innovation Board, with expectations for increased market activity, better understanding of long-term investments, and deeper integration of industry, academia, and research [5]